Titanium screw anchorage for traction of many impacted teeth in a patient with cleidocranial dysplasia.

S. Kuroda,T. Yanagita,H. Kyung,T. Takano-Yamamoto

DOI: https://doi.org/10.1016/J.AJODO.2005.06.026

IF: 2.711

2007-05-01

American Journal of Orthodontics and Dentofacial Orthopedics

Abstract:

What problem does this paper attempt to address?

Radiology of the resurfaced hip

Luthfur Rahman,M. Hall-Craggs,S. Muirhead-Allwood

DOI: https://doi.org/10.1007/s00256-010-1081-3

2011-04-05

Skeletal Radiology

Abstract:
Relation of serum potassium level to long-term outcomes in patients with acute myocardial infarction

Joon Seok Choi,Young A Kim,Ha Yeon Kim,Chan Young Oak,Yong Un Kang,Chang Seong Kim,Eun Hui Bae,Seong Kwon Ma,Young Keun Ahn,Myung Ho Jeong,Soo Wan Kim

DOI: https://doi.org/10.1016/j.amjcard.2014.01.402

2014-04-15

Abstract:Potassium plays a key role in normal myocardial function, and current guidelines recommend that serum potassium levels be maintained from 4.0 to 5.0 mEq/L in patients with acute myocardial infarction (AMI). However, the impact of serum potassium levels on long-term mortality has not been evaluated. We retrospectively studied 1,924 patients diagnosed with AMI. The average serum potassium levels measured throughout the hospitalization were obtained and statistically analyzed. Patients were categorized into 5 groups to determine the relation between mean serum potassium and long-term mortality: <3.5, 3.5 to <4.0, 4.0 to <4.5, 4.5 to <5.0, and ≥5 mEq/L. The long-term mortality was lowest in the group of patients with potassium levels of 3.5 to <4.0 mEq/L, whereas mortality was higher in the patients with potassium levels≥4.5 or <3.5 mEq/L. In a multivariate Cox-proportional regression analysis, the mortality risk was greater for serum potassium levels of >4.5 mEq/L (hazard ratio [HR] 1.71, 95% confidence interval [CI] 1.04 to 2.81 and HR 4.78, 95% CI 2.14 to 10.69, for patients with potassium levels of 4.5 to <5.0 mEq/L and ≥5.0, respectively) compared with patients with potassium levels of 3.5 to <4.0 mEq/L. The mortality risk was also higher for patients with potassium levels<3.5 mEq/L (HR 1.55, 95% CI 0.94 to 2.56). In contrast to the association with long-term mortality, there was no relation between serum potassium levels and the occurrence of ventricular arrhythmias. The results of the current analysis suggest that there is a need for change in our current concepts of the ideal serum potassium levels in patients with AMI.
Effect of Dynamic Potassium Change on In-Hospital Mortality, Ventricular Arrhythmias, and Long-Term Mortality in STEMI

Adnan Kaya,Muhammed Keskin,Mustafa Adem Tatlisu,Osman Kayapinar

DOI: https://doi.org/10.1177/0003319718784127

Angiology

Abstract:We evaluated the effect of serum potassium (K) deviation on in-hospital and long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who were normokalemic at admission. A total of 2773 patients with an admission serum K level of 3.5 to 4.5 mEq/L were retrospectively analyzed. The patients were categorized into 3 groups according to their K deviation: normokalemia-to-hypokalemia, normokalemia-to-normokalemia, and normokalemia-to-hyperkalemia. In-hospital mortality, long-term mortality, and ventricular arrhythmias rates were compared among the groups. In a hierarchical multivariable regression analysis, the in-hospital mortality risk was higher in normokalemia-to-hypokalemia (odds ratio [OR] 3.03; 95% confidence interval [CI], 1.72-6.82) and normokalemia-to-hyperkalemia groups (OR 2.81; 95% CI, 1.93-4.48) compared with the normokalemia-to-normokalemia group. In a Cox regression analysis, long-term mortality risk was also higher in normokalemia-to-hypokalemia (hazard ratio [HR] 3.78; 95% CI, 2.07-7.17) and normokalemia-to-hyperkalemia groups (HR, 2.97; 95% CI, 2.10-4.19) compared with the normokalemia-to-normokalemia group. Ventricular arrhythmia risk was also higher in normokalemia-to-hypokalemia group (OR 2.98; 95% CI, 1.41-5.75) compared with normokalemia-to-normokalemia group. The current study showed an increased in-hospital ventricular arrhythmia and mortality and long-term mortality rates with the deviation of serum K levels from normal ranges.
ATTACHMENT AND GROWTH OF BACTERIA ON SURFACES OF CONTINUOUS-CULTURE VESSELS

D. H. Larsen,R. Dimmick

DOI: https://doi.org/10.1128/jb.88.5.1380-1387.1964

IF: 3.2

1964-11-01

Journal of Bacteriology

Abstract:Don H. Larsen (Brigham Young University, Provo, Utah), and R. L. Dimmick. Attachment and growth of bacteria on surfaces of continuous-culture vessels. J. Bacteriol. 88:1380–1387. 1964.—Initial attempts to induce synchrony in a continuous culture of Serratia marcescens by alternating growth temperatures produced fluctuations in the population of a magnitude and at a density higher than predicted by theory. Without temperature change, the density in the 14-ml volume changed with dilution rate, but the total output of cells per hour remained constant, even at dilution rates greater than critical. When glass wool was added to the culture vessel, the total output per hour increased 30-fold. Nonlethal ultrasonic agitation applied to the vessel reduced the population density in continuous culture under both a static and a cyclic temperature program. The decrease in population density, when the washout rate was momentarily increased about tenfold, was less than theoretically predicted, and the subsequent rapid rise, when flow was terminated, indicated the presence of a reservoir of cells on the walls of the vessel continually discharging their progeny into the medium. Several genera were examined in the latter manner; it is estimated that in some cases as many as 90% (S. marcescens, Escherichia coli), and in others (Bacillus spp.) possibly none, of the cells in suspension arose from wall inhabitants. Growth of bacteria on the walls of continuous-culture vessels can significantly influence the population density and, hence, the kinetics of continuous growth.
Potassium Fluctuations Are Associated With Inhospital Mortality From Acute Myocardial Infarction. Soroka Acute Myocardial Infarction II (SAMI-II) Project

Arthur Shiyovich,Harel Gilutz,Ygal Plakht

DOI: https://doi.org/10.1177/0003319717740004

Angiology

Abstract:Potassium levels (K, mEq/L) fluctuate in patients with acute myocardial infarction (AMI). Potassium was reported to be associated with prognosis in patients with AMI; however, studies evaluating the prognostic value of K fluctuations in this setting are scarce. We retrospectively analyzed patients with AMI hospitalized in a tertiary medical center, through 2002 to 2012. Patients on chronic dialysis or mechanical ventilation were excluded. Based on all K values during hospitalization, minimal, maximal, and fluctuation (gap between 2 consecutive K) were recorded. Primary outcome was inhospital all-cause mortality. Overall, 10 032 patients were studied (age 68.1 ± 14.3 years, 65.4% males, 44.2% ST-segment elevation MI), of which 507 (3.7%) died in hospital. Potassium decreased during the first 2 to 3 days ( P for trend <.001), followed by stabilization ( P for trend = .807). Potassium in the extreme categories (<3.8 and ≥4.7) and absolute fluctuations >0.1 mEq/L were more common among nonsurvivors than survivors ( P < .001 each). In a multivariate analysis, combinations of minimal K <3.8 with maximal K ≥4.7 (odds ratio [OR] = 18.1), K ≥4.4 with fluctuation ≥0.1 (OR = 1.74), or <-0.1 (OR = 2.6) and minimal K after the first 2 admission days (OR = 2.07) were associated with increased risk of mortality ( P < .001 each). Potassium fluctuations, peak and nadir K, and its timing independently predict inhospital mortality in patients with AMI.
Serum potassium levels and in-hospital mortality in distinct phenotypes of myocardial infarction patients by machine learning clustering

S W Park,G M Park

DOI: https://doi.org/10.1093/eurheartj/ehae666.1730

IF: 39.3

2024-10-29

European Heart Journal

Abstract:Background Abnormal serum potassium levels are associated with an increased risk of mortality in patients with myocardial infarction (MI); however, it is unclear whether the impact of potassium levels on mortality risk varies depending on the characteristics of MI patients. Purpose We aimed to classify MI patients according to their clinical characteristics and explore the relationship between potassium levels and in-hospital mortality in distinct clusters of MI. Methods Using Medical Information Mart for Intensive Care (MIMIC) IV database, we identified 3,159 patients who admitted for the first time to the intensive care unit with a primary diagnosis of acute MI. Machine learning clustering was performed on this population based on available clinical and laboratory data. Results Three distinct clusters of MI patients were identified using clustering analysis: 1,455 (46%) in cluster 1, 587 (19%) in cluster 2, and 1,117 (35%) in cluster 3. Patients in cluster 2 were older, had the highest comorbidity burden, Sequential Organ Failure Assessment (SOFA) score, peak lactate, creatinine, peak troponin, N-terminal B-type natriuretic peptide (NT-proBNP) levels and the lowest hemoglobin levels among the 3 clusters. Patients in cluster 3 were younger, had the lowest comorbidity burden, SOFA score, peak lactate, creatinine, NT-proBNP levels. Patients belonging to cluster 1 had clinical characteristics intermediate to those of cluster 2 and 3, except for the lowest troponin level. In-hospital mortality was highest in cluster 2, followed by cluster 1 and then cluster 3. Patients in cluster 2 had the highest in-hospital mortality risk with hypokalemia (OR 3.71, 95% 1.81-7.63) and patients in cluster 3 had highest in-hospital mortality risk with hyperkalemia (OR 2.77, 95% CI 0.84-9.06). Patients in cluster 1 did not exhibit a linearly increasing mortality with hyperkalemia. Conclusions The use of clustering analysis in patients with acute MI could characterize baseline clinical data into clinically distinct clusters with different in-hospital mortality across the dyskalemia continuum. The results suggest that the optimal range of potassium levels in patients with MI may vary depending on patient characteristics.Figure - clusteringTable - K and In-hospital mortality

cardiac & cardiovascular systems
Patterns of Immunoglobulin Staining in Paraffin-Embedded Malignant Lymphomas

A. Leong,Hui Yin,Zenobia A M Hafajee

DOI: https://doi.org/10.1097/00129039-200206000-00003

2002-06-01

Abstract:The demonstration of immunoglobulin light chain restriction in paraffin-embedded B cell lymphomas is a capricious and difficult procedure that has been abandoned by many diagnostic laboratories. Using a combination of microwave antigen retrieval performed in a pressure cooker and proteolytic digestion with trypsin, we were able to demonstrate immunoglobulin light chain restriction in 66 B cell lymphomas comprising 25 follicular lymphomas, 29 diffuse large cell lymphomas, 6 small lymphocytic lymphomas, 2 mantle cell lymphomas, 1 nodal marginal zone lymphoma, 1 Burkitt lymphoma, 1 hairy cell leukemia, and 1 plasmacytoma. There was concordance of results in 13 cases in which flow cytometry immunoglobulin analyzes were performed. Perinuclear staining was demonstrated in all cases with dot-like staining of the Golgi present in 23 cases. Perinuclear staining occurred in combination with cytoplasmic staining in 12 cases and membrane staining in 8 cases with 12 lymphomas showing more than two patterns of staining.
Serum Potassium Levels and Mortality of Patients with Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort Studies

Hui Xi,Rong-Hui Yu,Ning Wang,Xue-Zhi Chen,Wen-Chao Zhang,Tao Hong

DOI: https://doi.org/10.1177/2047487318780466

IF: 8.526

2019-01-01

European Journal of Preventive Cardiology

Abstract:Background The evidence of current epidemiological studies investigating the association between serum potassium levels and mortality of acute myocardial infarction (AMI) patients is controversial and inadequate. Design Systematic review and meta-analysis. Methods Two researchers independently searched the PubMed, EMBASE and Web of Science databases to identify observational studies published prior to 31 October 2017. Similarly, two researchers separately extracted data and any differences were resolved by discussion. Pooled relative risks and 95% confidence intervals (CIs) were computed with an inverse variance-weighted random-effects model. Heterogeneity among studies was assessed with the I-2 statistic. Results Seven cohort studies were included for analysis. Compared with the reference group (3.5 to <4.0 mEq/L), the pooled relative risks of mortality were 1.15 (95% CI = 1.00-1.32), 1.09 (95% CI = 0.97-1.24), 1.42 (95% CI = 1.19-1.70) and 1.85 (95% CI = 1.39-2.47) for AMI patients with a potassium level of<3.5, 4.0 to <4.5, 4.5 to <5.0, and >= 5.0 mEq/L, respectively. For admission and post-admission potassium, although J-shaped associations were also indicated, non-significant results were observed for AMI patients with potassium levels of <3.5 mEq/L when compared with the reference group. Notably, in subgroup analyses of study characteristics, stratified by study quality, geographic location, type of outcome, number of cases, type of AMI, and adjustment for potential confounders, the findings were broadly consistent across strata. Conclusions These findings indicate that both lower (<3.5 mEq/L) and higher (>= 4.5 mEq/L) serum potassium levels are associated with an increased risk of mortality of patients with AMI.
Prognostic significance of serum potassium level for major adverse cardiac events and death in patients with coronary atherosclerotic disease

Afrasyab Altaf,Aftab Alam,Momin Salahuddin,Momin Khan,Mazhar Mahmood,Hammad Shah,Karamat Ali Shah

DOI: https://doi.org/10.5603/aa.2020.0010

2020-09-25

Acta Angiologica

Abstract:Introduction: Serum potassium levels have been shown in some animal studies to be associated with theprocess of atherosclerosis. We decided to assess the correlation of serum potassium level in ischemic heart diseasepatients with disease severity and its relationship with prognosis in terms of major acute cardiac events (MACE). Material and methods: This was a cross-sectional cohort study carried out at cardiology department of RehmanMedical Institute, from July 2016 to 31st Aug. 2018 a period of 26 months. 622 patients were included in thestudy. Clinical and angiographic characteristics were assessed based on the serum potassium level. Correlation ofserum potassium level with Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery(SYNTAX) and Gensini scores was also evaluated. Follow up for MACE was carried out after one year. Results: Mean serum potassium level was 3.93 ± 0.95 (mEq/l) in coronary artery disease patients. Serumpotassium level showed negative correlation with SYNTAX score (r = –0.60, p < 0.05) and Gensini score(r = –0.64, p < 0.05). There was also a significant difference between low and high potassium level in relationto the multi-vessel disease on coronary angiography (p < 0.05). Low potassium level was a good predictor ofadverse outcomes as shown by Kaplan-Meier analysis. Multivariate Cox regression analysis showed that serumpotassium level and diabetes were independent predictors of MACE (p < 0.05). Conclusion: Low serum potassium level is correlated with more severe coronary atherosclerosis. Low potassiumlevels are associated with significantly poor outcomes.
Care, needs, and resources.

A. Safir

1977-03-01

Abstract:
[Epidemiological studies of the incidence of the rheumatoid factor in a community of aged subjects].

R. Lunghetti,A. Bravi,N. Di Paolo,G. Bianco,G. Scalise

Abstract:
Dyskalemias and adverse events associated with discharge potassium in acute myocardial infarction.

Hong Xu,Jonas Faxén,Karolina Szummer,Marco Trevisan,Csaba P Kovesdy,Tomas Jernberg,Juan Jesús Carrero

DOI: https://doi.org/10.1016/j.ahj.2018.06.009

IF: 5.099

2018-01-01

American Heart Journal

Abstract:Background: The incidence of dyskalemias and associated outcomes in acute myocardial infarction (AMI) are unknown in real-world settings and likely differ from the controlled environment of randomized controlled trials. Methods: We examined consecutive survivors of an AMI during 2006-2011 in SWEDEHEART registry and with plasma potassium at discharge (exposure). Study outcomes were 1-year risk of hyperkalemia (potassium >5.0 mmol/L), hypokalemia (potassium <3.5 mmol/L), and others (1-year risk of death, new myocardial infarction, heart failure, and de novo atrial fibrillation). Covariates included demographics, comorbidities, hospital procedures, and medications. Results: We included 4,861 patients (65% male, age 71.4 +/- 12.6 years) with mean discharge potassium of 4.0 +/- 0.4mmol/L. Within 1 year, 784 (16.1%) new hyperkalemic and 991 (20.4%) new hypokalemic events occurred. Discharge potassium and kidney dysfunction were independent predictors of their occurrence. Compared with discharge potassium of 4.0 to <4.5mmol/L, the adjusted risk of incident hyperkalemia was 1.71 (95% confidence interval 1.41-2.06) for potassium of 4.5-5.0mmol/L and 2.38 (1.69-3.35) for potassium of >5.0mmol/L; the adjusted risk of incident hypokalemia was 1.43 for potassium of 3.5 to <4.0 mmol/L (1.23-1.66) and 3.12 (2.58-3.77) for potassium of <3.5 mmol/L. A U-shaped association was observed between discharge potassium and the risk of death (n=718), with increased hazards for potassium <3.5 and >4.5 mmol/L. No association was found between discharge potassium and the risk of new myocardial infarction, heart failure, or de novo atrial fibrillation. Conclusions: Among real-world AMI survivors, both hyperkalemia and hypokalemia are frequent. Discharge potassium and kidney function strongly predicted their occurrence, as well as the 1-year risk of death. (C) 2018 Elsevier Inc. All rights reserved.
Serum Potassium Levels and Risk of Sudden Cardiac Death Among Patients With Chronic Kidney Disease and Significant Coronary Artery Disease

Patrick H Pun,Benjamin A Goldstein,John A Gallis,John P Middleton,Laura P Svetkey

DOI: https://doi.org/10.1016/j.ekir.2017.07.001

2017-07-17

Abstract:Introduction: Chronic kidney disease (CKD) patients have increased risks of sudden cardiac arrest and sudden cardiac death (SCA/SCD) that are not explained by traditional risk factors. We examined associations between serum potassium and SCA/SCD in a large cohort of patients with coronary artery disease (CAD) and moderate CKD. Methods: Among 22,009 patients who underwent cardiac catheterization at our institution between 1999 and 2011, 6181 patients had an estimated glomerular filtration rate of ≤60 ml/min per 1.73 m2 and were not receiving renal replacement therapy. The risk of SCA/SCD and all-cause mortality associated with potassium concentration was evaluated at the time of cardiac catheterization (baseline) and most proximate to SCA/SCD events. Covariate-adjusted Cox models were used to examine relationships between baseline potassium measurements and outcomes. A propensity score-matched, case-control design was used to assess risk associations of potassium measurements obtained proximate to SCA events. Results: In the baseline potassium analysis, compared with levels in the normal range, there was no significant risk association between hyperkalemia (>5 mEq/l) or hypokalemia (<3.5 mEq/l) and SCA/SCD or all-cause death after covariate adjustment. In the proximate potassium analysis, hyperkalemia occurred more frequently than hypokalemia (16.7% vs. 3%), and was associated with a doubling in SCA/SCD risk (adjusted odd ratio: 2.37; 95% confidence interval: 1.33-4.23) whereas there was no significant relationship between hypokalemia and outcome. Discussion: Among CKD patients with significant CAD, elevated serum potassium levels >5.0 mEq/l are common and are associated with an increased short-term risk of SCA/SCD. Early detection and treatment of hyperkalemia may reduce the high risk of SCD among CKD patients.
Clinical Outcomes by Serum Potassium Levels for Patients Hospitalized for Heart Failure: Secondary Analysis of Data from the China National Heart Failure Registry.

Jingmin Zhou,Xuejuan Jin,Jun Zhou,Yamei Xu,Xiaotong Cui,Michael Fu,Kai Hu,Junbo Ge

DOI: https://doi.org/10.1002/clc.24114

2023-01-01

Clinical Cardiology

Abstract:Background: Dyskalemia is a mortality risk factor in patients with heart failure (HF). Hypothesis: We described the prevalence of dyskalemia, and clinical outcomes by serum potassium (sK) levels, in Chinese patients hospitalized for HF. Methods: In this secondary analysis of the prospective China National Heart Failure Registry, adult patients hospitalized between January 1, 2013 and June 30, 2015 who had at least one baseline sK measurement were followed for up to 3 years after discharge. The use of renin-angiotensin-aldosterone system inhibitors at baseline and clinical outcomes during follow-up were compared among sK groups. Results: Among 6950 patients, 5529 (79.6%) had normokalemia (sK >3.5-5.0 mmol/L), 1113 (16.0%) had hypokalemia (sK 0-3.5 mmol/L), and 308 (4.4%) had hyperkalemia (sK >5.0 mmol/L). Baseline characteristics that were most common in patients with hyperkalemia than those with hypo- and normokalemia included older age, HF with reduced ejection fraction, New York Heart Association Class III/IV status, hypertension, and chronic kidney disease. Use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) differed across sK groups (p = .0001); reported in 64.1%, 63.4%, and 54.5% of patients with hypo-, normo-, and hyperkalemia, respectively. Overall, 26.6%, 28.6%, and 36.0% of patients with hypo-, normo-, and hyperkalemia had rehospitalization for worsened HF, or cardiovascular mortality; p = .0057 for between-group comparison. Conclusions: Patients with hyperkalemia received ACEIs or ARBs for HF treatment at baseline less frequently than those with hypo- or normokalemia, and had worse prognoses. This warrants further investigation into effective hyperkalemia management in HF.
Potassium concentration on admission is an independent risk factor for target lesion revascularization in acute myocardial infarction

Tsuyoshi Honda,Kazuteru Fujimoto,Yuji Miyao,Hidenobu Koga,Masanobu Ishii

DOI: https://doi.org/10.1155/2014/946803

2014-01-12

Abstract:Background: Acute myocardial infarction (AMI) is accompanied by excessive production of catecholamines, which is characterized by a hypokalemic dip. A polymorphism of the adrenergic receptor has also been reported to be associated with target lesion revascularization (TLR) after coronary intervention. Subjects and methods: We enrolled 276 consecutive patients with AMI within 24 hours of symptom onset, who underwent emergency coronary intervention using bare metal stents and had examinations over a 5-10-month follow-up period. The patients were divided into tertiles based on their serum potassium level on admission (low K, <3.9; mid K, ≥ 3.9, <4.3; and high K, ≥ 4.3). Results: Sixty-four TLRs were observed in the study. Increased potassium concentration was associated significantly with TLR. Patients in the high K group were about two and a half times more likely to have a TLR after AMI compared to those in the low K group. Multiple logistic analysis showed that potassium level on admission was an independent risk factor for TLR (odds ratio 1.69; confidence interval 1.04 to 2.74; P = 0.036). Conclusions: These findings indicated that increased potassium levels on admission might predict TLRs in AMI patients treated with bare metal stents.
Serum potassium levels and outcomes in critically ill patients in the medical intensive care unit

Surat Tongyoo,Tanuwong Viarasilpa,Chairat Permpikul

DOI: https://doi.org/10.1177/0300060517744427

Abstract:Objective To compare the outcomes of patients with and without a mean serum potassium (K+) level within the recommended range (3.5-4.5 mEq/L). Methods This prospective cohort study involved patients admitted to the medical intensive care unit (ICU) of Siriraj Hospital from May 2012 to February 2013. The patients' baseline characteristics, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, serum K+ level, and hospital outcomes were recorded. Patients with a mean K+ level of 3.5 to 4.5 mEq/L and with all individual K+ values of 3.0 to 5.0 mEq/L were allocated to the normal K+ group. The remaining patients were allocated to the abnormal K+ group. Results In total, 160 patients were included. Their mean age was 59.3±18.3 years, and their mean APACHE II score was 21.8±14.0. The normal K+ group comprised 74 (46.3%) patients. The abnormal K+ group had a significantly higher mean APACHE II score, proportion of coronary artery disease, and rate of vasopressor treatment. An abnormal serum K+ level was associated with significantly higher ICU mortality and incidence of ventricular fibrillation. Conclusion Critically ill patients with abnormal K+ levels had a higher incidence of ventricular arrhythmia and ICU mortality than patients with normal K+ levels.
A Method for Detecting Life-Threatening Signals in Serum Potassium Level after Myocardial Infarction

Michal Shauly-Aharonov,Moshe Pollak,Ygal Plakht

DOI: https://doi.org/10.48550/arXiv.1602.06717

2016-02-22

Applications

Abstract:Clinical guidelines recommend maintaining serum potassium levels between 4.0 and 5.0 mEq/L in patients with acute myocardial infarction (MI). These guidelines are based on recent studies that found significant associations between crossing of absolute potassium limits (by in-hospital mean or by min/max values) and mortality. This paper investigates a different approach: we hypothesized that a change in the potassium level may be a harbinger of short survivability, rather than crossing of absolute boundaries. Our objectives were: (1) to examine if a "change in mean" indicator has the ability to distinguish between survivors and non-survivors of MI hospitalization, and if so, (2) to formulate a framework for detecting life-threatening changes in potassium level of patients hospitalized with MI. The study included 195 patients who were hospitalized for MI from 2002 to 2014, with at least 40 potassium measurements (i.e., severely ill). In a retrospective analysis we found evidence that the "change in mean" criterion significantly discriminated between survivors and non-survivors. A threshold for raising an alarm was specified by plotting an ROC curve and choosing the value that yields the best combination of sensitivity and specificity. In this case, the method detected ~80% of the patients that eventually died, while wrongly alerting for only ~40% of the survivors. The proposed approach is not intended for replacing the absolute-level protocols but to add valuable knowledge to cardiologists.
Serum Potassium and Angiographic Severity of Coronary Artery Disease in Non-ST Elevation Myocardial Infarction

P. Karmakar,Gokul Chandra Datta,Afzalur Rahman,A. Islam,K. A. Siddika,Md Nazmul Islam,Shaikat Chowdhury,A. Mamun,M. Sultana,Kazi Rubayet Anwar,D. Debnath

DOI: https://doi.org/10.3329/BHJ.V35I2.52899

2021-04-07

Abstract:Background: Non-ST elevation myocardial infarction (NSTEMI) patients like other patients with acute coronary syndrome (ACS) need assessment of severity of coronary artery disease (CAD) for prognostication and management. The available scoring systems are complex and include invasive parameters. On the other hand, potassium is a key element and its blood level has been shown to reflect health and disease of vasculature including in some ACS. Objective: The study was conducted to find out the relationship between serum potassium level and angiographic severity of CAD in NSTEMI. Method: A total of 200 cases of NSTEMI patients undergoing coronary angiography (CAG) were included. Patients getting medications that alter potassium homeostasis (e.g., diuretics, glucocorticoids, intravenous insulin), having renal impairment, haematological or liver disease, congenital or valvular heart disease, cardiomyopathy, prior percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) were excluded. Serum potassium was measured soon after admission with NSTEMI, and the patients were divided: mid to high normal (4 to 5.5 mmol/L) constituted the group I and low normal (3.5-3.9 mmol/L) constituted the group II. CAG was done during index admission, SYNTAX score calculated and compared between 2 groups. Results: High SYNTAX score was significantly more commonly found in group I than in group II (62.1% vs. 14.7%, p<0.001). Mean SYNTAX score was higher in group I than in group II (24.3±8.2 vs. 15.3±7.8, p<0.001). There was a linear relationship between serum potassium level and SYNTAX score. Mid to high normal serum potassium, hypertension and dyslipidemia were found to be significantly related to higher SYNTAX score with odds ratio being 10.44, 4.37 and 2.12 respectively. Conclusions: Within physiological limits, higher serum potassium level correlates with severe coronary artery disease in NSTEMI patients. It may be used as an additional tool in conjunction with other scoring systems to assess the severity of CAD in this subset of ACS patients.

Medicine
Clinical outcomes of serum potassium in patients with percutaneous coronary intervention: insights from a large single-center registry

Bingbing Ke,Aidong Shen,Hui Qiu,Weiping Li,Hui Chen,Hongwei Li

DOI: https://doi.org/10.3389/fcvm.2023.1216422

2023-08-10

Abstract:Background: Serum potassium homeostasis plays an important role in myocardial electrical stability, but the impact of altered serum potassium levels on the major adverse cardiovascular and cerebral events (MACCE) in patients with percutaneous coronary intervention (PCI) has not been evaluated. Aim: To evaluate the association between serum potassium level and the risk of MACCE in PCI patients. Materials and methods: This retrospective study involved 8,263 in-patients from a single-center registry who were successfully treated with PCI between January 2003 and December 2020. Clinical data were collected for 24 h after admission. Data were analyzed from June 2003 to December 2021. The primary outcome was MACCE, defined as a composite of all-cause death, myocardial infarction, revascularization, stroke, and heart failure-related hospitalization. Results: The median [interquartile range (IQR)] follow-up for all patients was 4.0 (2.1, 5.8) years, and 1,632 patients (19.7%) were diagnosed with MACCE. High serum potassium levels were associated with a 20% increased risk of MACCE (hazard ratio [HR]: 1.20, 95% confidence interval [CI]: 1.05-1.38, P = 0.008) and 72% increased risk of all-cause death (HR: 1.72, 95% CI: 1.39-2.14, P < 0.001). Multivariate Cox analysis showed that the risk of MACCE was higher in patients at the highest quartile of serum potassium (Q4 vs. Q1: adjusted HR: 1.18, 95% CI: 1.02-1.35, P = 0.026). Moreover, a higher serum potassium level was always associated with a higher risk of all-cause death (Q4 vs. Q1: adjusted HR: 1.50, 95% CI: 1.17-1.91, P = 0.001). A U-shaped relationship between serum potassium levels, MACCE, and all-cause death was derived in patients undergoing PCI. Serum potassium levels, maintained within the range of 3.8-4.0 mmol/L before PCI, exhibited the lowest risk of associated MACCE and all-cause death. Conclusion: Our results demonstrate that the serum potassium level could be associated with higher risks of MACCE and all-cause death in PCI patients. In particular, serum potassium levels maintained at 3.8-4.0 mmol/L before PCI could lower the risk of MACCE and all-cause death.
Serum Potassium Levels and Mortality in Hospitalized Heart Failure Patients

Bo-Ping Huang,Lang Zhao,Xue-Mei Zhao,Mei Zhai,Yan Huang,Qiong Zhou,Peng-Chao Tian,Lin Liang,Li-Yan Huang,Jia-Yu Feng,Yu-Hui Zhang,Jian Zhang

DOI: https://doi.org/10.31083/j.rcm2408228

2023-08-09

Abstract:Background: To assess the link between serum potassium ( K + ) and all-cause mortality in hospitalized heart failure (HF) patients. Methods: Hospitalized HF patients (n = 3114) were analyzed at the Fuwai Hospital Heart Failure Center. Before discharge, HF patients were divided into four groups according to the K + level quartiles: K + ≤ 3.96 mmol/L (Q1), 3.96 < K + ≤ 4.22 mmol/L (Q2), 4.22 < K + ≤ 4.52 mmol/L (Q3), and K + > 4.52 mmol/L (Q4). At 90 days, 2 years, and maximal follow-up, all-cause mortality was the primary outcome. Results: Patients with HF in the Q4 group had worse cardiac function, higher N-terminal pro-B-type natriuretic peptide levels, lower left ventricular ejection fractions and lower estimated glomerular filtration rates than patients in the Q2 group. In the multivariate-adjusted Cox analysis, the mortality assessed during the 90-day, 2-year, and maximal follow-up examinations increased in the Q4 group of HF patients but not in the Q1 and Q3 groups. The Q4 group had a 28% (hazard ratio [HR]: 1.28, 95% confidence interval [CI]: 1.09-1.49, p = 0.002) higher risk of all-cause mortality at maximum follow-up. Hypokalemia and hyperkalemia were linked to increased HF mortality risk at the 90-day, 2-year, and maximal follow-up periods. Conclusions: Serum K + levels had a J-shaped association with all-cause mortality in HF patients. Both hypokalemia and a K + level of > 4.52 mmol/L were associated with increased all-cause mortality in the short term and long term, suggesting a narrow target K + range in HF patients. Clinical trial registration: Unique Identifier: NCT02664818; URL: clinicaltrials.gov.

Titanium screw anchorage for traction of many impacted teeth in a patient with cleidocranial dysplasia.

Radiology of the resurfaced hip

Relation of serum potassium level to long-term outcomes in patients with acute myocardial infarction

Effect of Dynamic Potassium Change on In-Hospital Mortality, Ventricular Arrhythmias, and Long-Term Mortality in STEMI

ATTACHMENT AND GROWTH OF BACTERIA ON SURFACES OF CONTINUOUS-CULTURE VESSELS

Potassium Fluctuations Are Associated With Inhospital Mortality From Acute Myocardial Infarction. Soroka Acute Myocardial Infarction II (SAMI-II) Project

Serum potassium levels and in-hospital mortality in distinct phenotypes of myocardial infarction patients by machine learning clustering

Patterns of Immunoglobulin Staining in Paraffin-Embedded Malignant Lymphomas

Serum Potassium Levels and Mortality of Patients with Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort Studies

Prognostic significance of serum potassium level for major adverse cardiac events and death in patients with coronary atherosclerotic disease

Care, needs, and resources.

[Epidemiological studies of the incidence of the rheumatoid factor in a community of aged subjects].

Dyskalemias and adverse events associated with discharge potassium in acute myocardial infarction.

Serum Potassium Levels and Risk of Sudden Cardiac Death Among Patients With Chronic Kidney Disease and Significant Coronary Artery Disease

Clinical Outcomes by Serum Potassium Levels for Patients Hospitalized for Heart Failure: Secondary Analysis of Data from the China National Heart Failure Registry.

Potassium concentration on admission is an independent risk factor for target lesion revascularization in acute myocardial infarction

Serum potassium levels and outcomes in critically ill patients in the medical intensive care unit

A Method for Detecting Life-Threatening Signals in Serum Potassium Level after Myocardial Infarction

Serum Potassium and Angiographic Severity of Coronary Artery Disease in Non-ST Elevation Myocardial Infarction

Clinical outcomes of serum potassium in patients with percutaneous coronary intervention: insights from a large single-center registry

Serum Potassium Levels and Mortality in Hospitalized Heart Failure Patients